COMPARATIVE STUDY
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Expression of caspase-3, Bax nad Bcl-2 in placentas from pregnancies complicated by treated and non-treated fetal growth restriction.

Ginekologia Polska 2009 September
BACKGROUND: Fetal growth restriction (FGR) is the reason of high prematurity rate and its later complications. Restriction of utero-placental circulation, which could be changed by IURG treatment, plays the main role in FGR. The results of changes in apoptosis-related genes expression due to FGR treatment may help further in the prevention and treatment of FGR.

MATERIAL AND METHODS: Caspase-3, Bax and Bcl-2 expressions in normal pregnancies and those complicated by treated and untreated FGR have been compared. The study was conducted in 2005-2006 at the High-Risk Pregnancy Unit of Medical University in Łódź and Kopernik Hospital in Łódź. Caspase-3, Bax and Bcl-2 expressions were assessed by immunohistochemical method Bcl-2 was assessed in the trophoblast, Bax and caspase-3 in the decidua and the trophoblast.

RESULTS: The mean value of Bcl-2 in the trophoblast was 58.8 +/- 12.7 in the FGR-untreated group, 37.0 +/- 0.5 in the FGR-treated group and 65.7 +/- 6.9 in the control group. In the FGR-untreated group the mean value of Bax expression was 60.6 +/- 10.7 in the trophoblast and 32.0 +/- 7.3 in the decidua. In the FGR-treated group the mean value of Bax expression was 42.2 +/- 12.2 in the trophoblast and 20.9 +/- 6.4 in the decidua. In the control group the mean value of Bax expression was 13.6 +/- 2.2 in the trophoblast and 6.6 +/- 6.8 in the decidua. In the FGR-untreated group the mean value of Cpp-32 expression was 40.1 +/- 9.1 in the trophoblast and 42.6 +/- 12.5 in the decidua. In the FGR-treated group the mean value of Cpp-32 expression was 21.3 +/- 6.8 in the trophoblast and 23.7 +/- 5.1 in the decidua. In the control group the mean value of Cpp-32 expression was 13.6 +/- 6.3 in trophoblast and 11.6 +/- 5.3 in the decidua.

CONCLUSIONS: Increased expression of pro-apoptotic proteins in the placenta might be one of the reasons for FGR development. The treatment used in the FGR group decreased the process of apoptosis.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app